InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018

InMed Pharmaceuticals Inc. (CNW Group/InMed Pharmaceuticals Inc.)

This information was provided by prnewswire

Send your Press Release here.


VANCOUVER, Oct. 10, 2018 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will be presenting at the BIO Investor Forum on Wednesday, October 17, 2018 at 9:30 AM PT / 12:30 PM ET at the Westin St. Francis, in San Francisco, California.  The presentation will be webcast, the link to which may be found on the Company’s website, or below.


Conference Call & Webcast:
Wednesday, Oct. 17, 2018 at 9:30 AM Pacific Time, 12:30 PM Eastern Time
Webcast replay available: 1 hour after conclusion of live event
Webcast replay expires: January 15, 2019


Related Posts

Hello! I am your Publisher and fellow reader. Find the magazine online and in print throughout the state of California!

Leave a Reply

Your email address will not be published. Required fields are marked *

The Emerald Magazine
Close Cookmode
WP Facebook Auto Publish Powered By :